Skip to main content

Table 1 Demographics

From: Clinical utility of cardiac magnetic resonance T2 mapping for acute myocardial edema

Total cases

65

    

Group

Controls

Transplant

AMI

Myocarditis

Cardiomyopathy

Average age

32.7 ± 7.3

55.8 ± 13.8

55.5 ± 10.3

49.2 ± 13.2

60

Percent female

50%

44%

33%

33%

100%

Normal**

20

22

4

3

0

Disease

NA

3

8

3

1

Total

20

25

12

6

1

Outcomes

     

Average T2 Normal ROI (ms)

51.2 ± 2.7

52.1 ± 2.4

54.1 ± 3.1

54.0 ± 3.7

52.3 ± 3.1

Average T2 Disease ROI (ms)

NA

61.6 ± 3.1

65.0 ± 4.4

67.1 ± 7.5

68.0 ± 4.2

Significance

NA

<0.05

<0.05

<0.05

<0.05*

Ejection fraction

62%

58.7%

39.$%

41/1%

32.2%

  1. *p-value compared internally from basal segment to mid and apical segment
  2. ** Normal represents cases that were suspected to have outcome, i.e. AMI, myocarditis, etc, but were by clinical assessment MRI, and cellular pathology determined not to have any disease. These cases T2 Mapping were compared to cases with in-group pathology.